LCN2 and acute kidney injury: Irrespective of the underlying mechanisms, measurement of urine hepcidin concentrations, combined with measurements of one or more other biomarkers (that is, lipocalin 2), may provide additional information for the early identification of individuals who will or will not develop AKI.